Eam Investors, LLC Penumbra Inc Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$271.54 - $344.06 $3,530 - $4,472	13 Added 0.31%	4,148 $1.43 Million
Q1 2023 Jul 12, 2023	BUY	$220.43 - $278.69 $911,478 - $1.15 Million	4,135 New	4,135 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$151.88 - $228.5 $848,857 - $1.28 Million	5,589 New	5,589 $1.24 Million
Q3 2018 Nov 08, 2018	SELL	$121.55 - $156.8 $2.51 Million - $3.23 Million	-20,612 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$112.2 - $165.95 $857,544 - $1.27 Million	-7,643 Reduced 27.05%	20,612 $2.85 Million
Q1 2018 May 14, 2018	BUY	$84.6 - $126.1 $741,349 - $1.11 Million	8,763 Added 44.96%	28,255 $3.27 Million
Q4 2017 Feb 12, 2018	SELL	$91.55 - $115.85 $402,179 - $508,929	-4,393 Reduced 18.39%	19,492 $1.83 Million
Q3 2017 Nov 08, 2017	BUY	$79.65 - $90.3 $1.9 Million - $2.16 Million	23,885	23,885 $2.16 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.